{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:53:10Z","timestamp":1791247990103,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-07277-5","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:54:52Z","timestamp":1783486492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sustained seropositivity up to eight years after two-dose inactivated hepatitis A vaccination in Turkish children: a retrospective observational study"],"prefix":"10.1186","volume":"26","author":[{"given":"\u00d6zlem","family":"Aydemir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"K\u00f6ro\u011fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"\u00d6\u011f\u00fctl\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O\u011fuz","family":"Karabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131","family":"Vatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"\u00c7etin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"7277_CR1","unstructured":"World Health Organization. Hepatitis A. https:\/\/www.who.int (Accessed 08 Nov 2024)."},{"issue":"10","key":"7277_CR2","doi-asserted-by":"publisher","first-page":"a031716","DOI":"10.1101\/cshperspect.a031716","volume":"8","author":"KH Jacobsen","year":"2018","unstructured":"Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med. 2018;8(10):a031716. https:\/\/doi.org\/10.1101\/cshperspect.a031716.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"7277_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.35440\/hutfd.1423081","volume":"21","author":"S Aslan","year":"2024","unstructured":"Aslan S, \u015eahin A, Do\u011fantekin E, Do\u011fantekin A, G\u00fcrb\u00fcz H. Seroprevalence and endemic change in Gaziantep Province. J Harran Univ Med Fac. 2024;21(1):113\u20137. https:\/\/doi.org\/10.35440\/hutfd.1423081.","journal-title":"J Harran Univ Med Fac"},{"key":"7277_CR4","doi-asserted-by":"publisher","first-page":"4263309","DOI":"10.1155\/2023\/4263309","volume":"2023","author":"O Gholizadeh","year":"2023","unstructured":"Gholizadeh O, et al. Hepatitis A: viral structure, classification, life cycle, clinical symptoms, diagnosis error, and vaccination. Can J Infect Dis Med Microbiol. 2023;2023:4263309. https:\/\/doi.org\/10.1155\/2023\/4263309.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"7277_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15585\/mmwr.su6501a6","volume":"65","author":"TV Murphy","year":"2016","unstructured":"Murphy TV. Progress toward eliminating hepatitis A disease in the United States. MMWR Suppl. 2016;65(1):29\u201341. https:\/\/doi.org\/10.15585\/mmwr.su6501a6.","journal-title":"MMWR Suppl"},{"key":"7277_CR6","unstructured":"CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1996;45(RR-15):1\u201330."},{"key":"7277_CR7","unstructured":"CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48(RR-12):1\u201337."},{"key":"7277_CR8","unstructured":"CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-7):1\u201323."},{"issue":"2","key":"7277_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.vaccine.2021.01.038","volume":"40","author":"A Andani","year":"2022","unstructured":"Andani A, van Damme P, Bunge EM, et al. One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: a systematic review. Vaccine. 2022;40(2):196\u2013205. https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.038.","journal-title":"Vaccine"},{"issue":"3","key":"7277_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.4161\/hv.27124","volume":"10","author":"ZY Xu","year":"2014","unstructured":"Xu ZY, Wang XY. Live attenuated hepatitis A vaccines developed in China. Hum Vaccin Immunother. 2014;10(3):659\u201366. https:\/\/doi.org\/10.4161\/hv.27124.","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"7277_CR11","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1080\/21645515.2017.1358326","volume":"13","author":"C Espul","year":"2017","unstructured":"Espul C, et al. Seven-year follow-up of immune response after one or two doses of inactivated hepatitis A vaccine. Hum Vaccin Immunother. 2017;13(11):2707\u201312. https:\/\/doi.org\/10.1080\/21645515.2017.1358326.","journal-title":"Hum Vaccin Immunother"},{"issue":"37","key":"7277_CR12","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1016\/j.vaccine.2011.06.069","volume":"29","author":"Z Kurug\u00f6l","year":"2011","unstructured":"Kurug\u00f6l Z, Aslan A, T\u00fcrko\u011flu E, et al. Changing epidemiology of hepatitis A infection in Izmir, T\u00fcrkiye. Vaccine. 2011;29(37):6259\u201361. https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.069.","journal-title":"Vaccine"},{"issue":"2","key":"7277_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5152\/tjg.2018.17431","volume":"29","author":"Z Karacaer","year":"2018","unstructured":"Karacaer Z, Tosun S, Bat\u0131rel A, et al. Changes in acute viral hepatitis epidemiology in the Turkish adult population. Turk J Gastroenterol. 2018;29(2):177\u201382. https:\/\/doi.org\/10.5152\/tjg.2018.17431.","journal-title":"Turk J Gastroenterol"},{"key":"7277_CR14","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1186\/s12889-024-20783-4","volume":"24","author":"S\u00d6 Karakaya","year":"2024","unstructured":"Karakaya S\u00d6, Bekta\u015f M, Alt\u0131ndi\u015f M, et al. Examining the changes in the prevalence of hepatitis A in T\u00fcrkiye: systematic review and meta-analysis. BMC Public Health. 2024;24:3280. https:\/\/doi.org\/10.1186\/s12889-024-20783-4.","journal-title":"BMC Public Health"},{"key":"7277_CR15","unstructured":"Republic of T\u00fcrkiye Ministry of Health. Turkey Viral Hepatitis Prevention and Control Program 2018\u20132023. Ankara: Republic of T\u00fcrkiye Ministry of Health; 2018."},{"issue":"1","key":"7277_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/INF.0000000000000042","volume":"33","author":"C Vizzotti","year":"2014","unstructured":"Vizzotti C, Gonz\u00e1lez J, Gentile A, et al. Impact of the single-dose immunization strategy against hepatitis A in Argentina. Pediatr Infect Dis J. 2014;33(1):84\u20138. https:\/\/doi.org\/10.1097\/INF.0000000000000042.","journal-title":"Pediatr Infect Dis J"},{"key":"7277_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2893.2008.01032.x","volume":"2","author":"G Chodick","year":"2008","unstructured":"Chodick G, Heymann AD, Ashkenazi S, et al. Long-term trends in hepatitis A incidence following vaccination. J Viral Hepat. 2008;2:62\u20135. https:\/\/doi.org\/10.1111\/j.1365-2893.2008.01032.x.","journal-title":"J Viral Hepat"},{"issue":"1","key":"7277_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.vaccine.2020.11.030","volume":"39","author":"P Juliao","year":"2021","unstructured":"Juliao P, Abadia I, Welby S, et al. Hepatitis A antibody persistence 8 and 10 years after vaccination. Vaccine. 2021;39(1):26\u201334. https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.030.","journal-title":"Vaccine"},{"issue":"42","key":"7277_CR19","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1016\/j.vaccine.2012.07.029","volume":"30","author":"LM Erhart","year":"2012","unstructured":"Erhart LM, Ernst KC. Changing epidemiology of hepatitis A in Arizona. Vaccine. 2012;30(42):6103\u201310. https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.029.","journal-title":"Vaccine"},{"issue":"28","key":"7277_CR20","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1016\/j.vaccine.2015.04.100","volume":"33","author":"D Estripeaut","year":"2015","unstructured":"Estripeaut D, Contreras R, Tinajeros O, et al. Impact of hepatitis A vaccination in Panama. Vaccine. 2015;33(28):3200\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.100.","journal-title":"Vaccine"},{"key":"7277_CR21","doi-asserted-by":"publisher","first-page":"9762","DOI":"10.1038\/s41598-023-36739-4","volume":"13","author":"J Enkelmann","year":"2023","unstructured":"Enkelmann J, Kuhnert R, Stark K, et al. Hepatitis A seroprevalence in Germany. Sci Rep. 2023;13:9762. https:\/\/doi.org\/10.1038\/s41598-023-36739-4.","journal-title":"Sci Rep"},{"key":"7277_CR22","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/INF.0b013e3181d57a85","volume":"29","author":"EL L\u00f3pez","year":"2010","unstructured":"L\u00f3pez EL, Contrini MM, Mistchenko A, Debbag R. Long-term immunity after hepatitis A vaccination. Pediatr Infect Dis J. 2010;29:568\u201370.","journal-title":"Pediatr Infect Dis J"},{"issue":"30","key":"7277_CR23","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1016\/j.vaccine.2010.04.096","volume":"28","author":"GL Bian","year":"2010","unstructured":"Bian GL, Ma R, Dong HJ, et al. Long-term immunogenicity of hepatitis A vaccine in children. Vaccine. 2010;28(30):4798\u2013801.","journal-title":"Vaccine"},{"issue":"2","key":"7277_CR24","doi-asserted-by":"publisher","first-page":"2227549","DOI":"10.1080\/21645515.2023.2227549","volume":"19","author":"X Wang","year":"2023","unstructured":"Wang X, Xu W, Hu Y, et al. Long-term follow-up of hepatitis A vaccines. Hum Vaccin Immunother. 2023;19(2):2227549.","journal-title":"Hum Vaccin Immunother"},{"key":"7277_CR25","unstructured":"Abadia I, Wong D, Rengifo A, et al. Eight years follow-up of the immune response in children after one or two doses of inactivated hepatitis A vaccine in Panama. In: International Pediatric Association (IPA) Congress; 17\u201321 Mar 2019; Panama City, Panama. 2019."},{"key":"7277_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12879-020-05247-5","volume":"20","author":"A Acikgoz","year":"2020","unstructured":"Acikgoz A, Cimrin D, Kizildag S, et al. Hepatitis A seropositivity among healthcare students in T\u00fcrkiye. BMC Infect Dis. 2020;20:529.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07277-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07277-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07277-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:07:52Z","timestamp":1791245272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-07277-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7277"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07277-5","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study approval was obtained from the ethics committee of Sakarya University Faculty of Medicine for this study (dated 28.03.2023 and numbered 175) As this was a retrospective study using previously collected data, the requirement for informed consent was waived. All procedures were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"950"}}